Vote Scores

Home / Companies / Beijing Tiantan Biological Products Corp. Ltd. / 29 May 2024

Meeting · year to 30 June 202430 filers reporting

Beijing Tiantan Biological Products Corp. Ltd.: meeting of 29 May 2024

Votes reported on Form N-PX, item by item

30 Form N-PX filers reported votes at the Beijing Tiantan Biological Products Corp. Ltd. meeting of 29 May 2024. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

49 vote records from 30 filers. 0 of the 30 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management30 filers100.0% for0.0% against0.0% against management7,165,333 reported shares
2

EXTRAORDINARY TRANSACTIONSIssuer

EXTRAORDINARY TRANSACTIONS: management items

Management items in this category are shown together; filers word and number them differently.

6 vote records from 3 filers. 0 of the 3 filers that marked the item either way voted against management.

33.3% for0.0% against66.7% other0.0% against management3 filers94.4% for5.6% against5.6% against management296,082 reported shares, counted once per item in this group
3

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

95 vote records from 30 filers. 0 of the 30 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management30 filers100.0% for0.0% against0.0% against management14,182,625 reported shares, counted once per item in this group
4

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

472 vote records from 30 filers. 2 of the 30 filers that marked the item either way voted against management.

43.3% for6.7% against50.0% other6.7% against management30 filers62.4% for37.6% against37.6% against management70,765,084 reported shares, counted once per item in this group
5

OTHERIssuer

OTHER: management items

Management items in this category are shown together; filers word and number them differently.

15 vote records from 3 filers. 0 of the 3 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management3 filers97.8% for2.2% against2.2% against management740,205 reported shares, counted once per item in this group

How the largest families voted

Family1. Auditor
VanguardFor
BlackRock and iSharesFor
FidelityFor
DimensionalFor
State Street and SPDRFor
Franklin TempletonFor
InvescoFor
Charles SchwabFor
Nuveen and TIAAFor
John Hancock and ManulifeFor
Morgan Stanley, Eaton Vance and CalvertFor
Northern Trust and FlexSharesFor
SEIFor
VoyaFor
Russell InvestmentsFor
BNY MellonFor
Pacific Life fundsFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Beijing Tiantan Biological Products Corp. Ltd. meeting?

30 Form N-PX filers reported votes at the meeting of 29 May 2024. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Beijing Tiantan Biological Products Corp. Ltd. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Beijing Tiantan Biological Products Corp. Ltd.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Beijing Tiantan Biological Products Corp. Ltd. with a meeting date within three days of 29 May 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.